Toronto adds ex-Guardian reliever with heartwarming story

The Toronto Blue Jays added a long-term addition with a strong personal story on Wednesday, agreeing to a two-year minor league deal with right-hander Nick Enright as the organization looks ahead beyond the 2026 season.

The Blue Jays reached a deal knowing that Enright will spend the entire 2026 campaign rehabbing from Tommy John surgery. The structure allows the Blue Jays to oversee his recovery without committing to the 40-man roster, creating flexibility while maintaining control over a pitcher who had shown a high level of efficiency before his injury.

Enright, 28, last appeared during the 2025 season Cleveland Guardianswhere he has quietly emerged as a reliable late-inning option. Through 31 innings, the former Guardians slugger posted a 2.03 ERA and consistently limited hard contact before undergoing elbow surgery late in the year. That performance made it an attractive low-risk investment despite the extended recovery time frame.

Details of the deal and Enright’s medical were first made public on Wednesday morning.

ESPN’s Alden Gonzalez took his X (formerly known as Twitter), sharing details of the minor league deal the club reached with the former Guardians pitcher.

“Source: Blue Jays agree to two-year minor league deal with RH Nick Enright.

Enright, 28, beat Hodgkin’s lymphoma and had a really nice year with the 2025 Guardians, posting a 2.03 ERA in 31 innings.

He will spend 2026 rehabbing Tommy John and will look to return in 2027.

Beyond the results on the field, the veteran reliever’s path back to professional pitching has been defined by resilience. He was diagnosed with Hodgkin’s lymphoma earlier in his career and successfully returned to the mound after treatment, re-establishing himself at the major league level before facing another major setback.

for The Blue Jays, this move represents a strategic approach to fence construction. By securing Enright now, the club positions itself to potentially add a proven arm in 2027 without immediate pressure on the roster. The deal balances patience with upside and aligns with the organization’s broader focus on depth, flexibility and long-term planning as Toronto prepares for the 2026 season.